表紙
市場調査レポート

フィブリノゲン欠乏症(第T因子欠乏症):世界の治験レビュー

Fibrinogen Deficiency (Factor I deficiency) Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 315195
出版日 ページ情報 英文 60 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
フィブリノゲン欠乏症(第T因子欠乏症):世界の治験レビュー Fibrinogen Deficiency (Factor I deficiency) Global Clinical Trials Review, H2, 2014
出版日: 2014年09月30日 ページ情報: 英文 60 Pages
概要

当レポートでは、フィブリノゲン欠乏症(第I因子欠乏症)に関する臨床研究の最新動向について分析し、疾患治療法の概要や、治験における主要国、G7諸国およびE7(新興7カ国)における治験数および被験者採用の状況、フェーズ(相)段階別の進行状況、有望なスポンサー、各企業研究機関での研究の進行状況、有望な薬剤の比較といった情報をまとめてお届けします。

目次

イントロダクション

  • フィブリノゲン欠乏症(第I因子欠乏症)
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東およびアフリカにおける治験件数

G7諸国での治験件数:血液疾患の治験件数に対するフィブリノゲン欠乏症(第I因子欠乏症)の治験件数比率

G7諸国での治験件数:フェーズ(相)別

G7諸国での治験件数:進捗状況別

E7諸国(新興7カ国)での治験件数:血液疾患の治験件数に対するフィブリノゲン欠乏症(第I因子欠乏症)の治験件数比率

E7諸国(新興7カ国)での治験件数:フェーズ(相)別

E7諸国(新興7カ国)での治験件数:進捗状況別

フェーズ(相)別の治験件数

  • 進行中の治験:フェーズ(相)別

進捗状況別の治験件数

エンドポイント達成状況別の治験件数

一定期間に採用された被験者

スポンサーの種類別治験件数

有望なスポンサー

有望な薬剤

最新の治験情報

治験のプロファイル

  • 代表的な企業の治験概要
    • CSL Limited
    • LFB S.A.
    • Octapharma AG
    • China Biologic Products, Inc.
    • Biotest AG
  • 代表的な大学・研究所における治験の概要
    • Guy's and St Thomas' NHS Foundation Trust
    • St. Antonius Hospital

5つの代表的な治験のプロファイル

付録

図表一覧

目次

GlobalData's clinical trial report, "Fibrinogen Deficiency (Factor I deficiency) Global Clinical Trials Review, H2, 2014" provides data on the Fibrinogen Deficiency (Factor I Deficiency) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fibrinogen Deficiency (Factor I Deficiency). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Fibrinogen Deficiency (Factor I Deficiency). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Fibrinogen Deficiency (Factor I deficiency)
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Fibrinogen Deficiency (Factor I deficiency) to Hematological Disorders Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Fibrinogen Deficiency (Factor I deficiency) to Hematological Disorders Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Fibrinogen Deficiency (Factor I deficiency) Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • CSL Limited
      • Clinical Trial Overview of CSL Limited
      • LFB S.A.
      • Clinical Trial Overview of LFB S.A.
      • Octapharma AG
      • Clinical Trial Overview of Octapharma AG
      • China Biologic Products, Inc.
      • Clinical Trial Overview of China Biologic Products, Inc.
      • Biotest AG
      • Clinical Trial Overview of Biotest AG
    • Clinical Trial Overview of Top Institutes / Government
      • Guy's and St Thomas' NHS Foundation Trust
      • Clinical Trial Overview of Guy's and St Thomas' NHS Foundation Trust
      • St. Antonius Hospital
      • Clinical Trial Overview of St. Antonius Hospital
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics, Global, Clinical Trials by Region, 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Proportion of Fibrinogen Deficiency (Factor I deficiency) to Hematological Disorders Clinical Trials, G7 Countries (%), 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Fibrinogen Deficiency (Factor I deficiency) to Hematological Disorders Clinical Trials, E7 Countries (%), 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics Clinical Trials Market, Global, Clinical Trials by CSL Limited, 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics Clinical Trials Market, Global, Clinical Trials by LFB S.A., 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics Clinical Trials Market, Global, Clinical Trials by Octapharma AG, 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics Clinical Trials Market, Global, Clinical Trials by China Biologic Products, Inc., 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics Clinical Trials Market, Global, Clinical Trials by Biotest AG, 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics Clinical Trials Market, Global, Clinical Trials by Guy's and St Thomas' NHS Foundation Trust, 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Antonius Hospital, 2014*

List of Figures

  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Proportion of Fibrinogen Deficiency (Factor I deficiency) to Hematological Disorders Clinical Trials, G7 Countries (%), 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Fibrinogen Deficiency (Factor I deficiency) to Hematological Disorders Clinical Trials, E7 Countries (%), 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Fibrinogen Deficiency (Factor I deficiency) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top